Paeds · neurology-neurodisability-and-neuromuscular

Sleep disorders with neurological disease

Also known as Paediatric sleep disorders · Sleep disturbance in neurodisability · Sleep-disordered breathing in cerebral palsy · Narcolepsy in childhood · Restless legs syndrome in children · Parasomnias in children

Fellowship guide to sleep disorders with neurological disease: the four-cluster framework of dyssomnias, sleep-disordered breathing, parasomnias, and sleep-related movement disorders, the bidirectional mechanism linking sleep to seizures, cognition, behaviour, and tone, the high-yield case-finding history and validated questionnaires, the targeted investigation pathway from polysomnography to the multiple sleep latency test and cerebrospinal fluid orexin, the stepped management built on sleep hygiene and behavioural therapy with melatonin, iron, airway support, and ventilation, and the evidence base for melatonin in autism and intravenous ferric carboxymaltose in restless legs syndrome.

high12 referencesUpdated 16 July 202626 min readVerification in progress

Practise this topic

On this page & tools

Your progress

Saved locally on this device.

Practise this topic

Target exams

RACP General PaediatricsRACP DWERACP DCEMRCPCH TheoryMRCPCH ClinicalABP General PediatricsRCPSC Pediatrics

Red flags

A previously well child with irresistible daytime sleep and sudden emotion-triggered loss of muscle tone has cataplexy, which is pathognomonic for narcolepsy type 1 and demands urgent sleep specialist referralA child with neuromuscular disease or severe cerebral palsy who develops morning headache, daytime sleepiness, or morning confusion may have symptomatic nocturnal hypoventilation progressing to respiratory failure and needs urgent oximetry and capnographyA nocturnal event that is stereotyped, brief, and occurs several times a night, or in more than the first third of the night, is more likely nocturnal frontal lobe epilepsy than a parasomnia and needs video-electroencephalographyWitnessed apnoeas, snoring, and restless sleep in a child with cerebral palsy or Down syndrome signal obstructive sleep apnoea that can cause cor pulmonale and neurocognitive decline if untreatedRestless sleep, bedtime resistance, and a family history of restless legs with a low ferritin point to restless legs syndrome, which a sedative will worsen but iron will helpChronic insomnia in a child with autism that persists despite good sleep hygiene should prompt consideration of prolonged-release melatonin, but never as a first-line substitute for behavioural measures

Life stages

infantpreschoolschool-ageadolescentyoung-adult-transition

Care settings

preventive-medical-homecommunity-schooloutpatientwardpicutelehealth

Clinical exam formats

written-only

Board mappings

Recognises that sleep disturbance is bidirectional with neurological disease and screens every neurodisability and epilepsy patient with a sleep history and a validated questionnaireDistinguishes the common sleep disorders by cluster: dyssomnias, sleep-disordered breathing, parasomnias, and sleep-related movement disordersInitiates sleep hygiene and behavioural therapy and refers for polysomnography when sleep-disordered breathing or narcolepsy is suspectedJustifies the targeted investigation pathway: polysomnography for breathing and movement disorders, multiple sleep latency test and cerebrospinal fluid orexin for narcolepsy, ferritin for restless legsManages sleep-disordered breathing of cerebral palsy and neuromuscular disease from adenotonsillectomy through continuous positive airway pressure to non-invasive ventilationDistinguishes nocturnal frontal lobe epilepsy from disorders of arousal using video-electroencephalography and treats the causeThe bidirectional relationship between sleep and neurological disease and the four-cluster classificationNarcolepsy type 1: orexin loss, cataplexy, multiple sleep latency test criteria, and orexin below 110 pg per mLThe stepped management from sleep hygiene through melatonin, iron, airway and ventilatory support, and specialist pharmacotherapyTakes a structured sleep history, uses a sleep diary and validated questionnaire, and performs a focused examination targeting airway, tone, and developmentBuilds a stepped management plan with the family and explains that treating sleep improves seizures, behaviour, and cognitionCoordinates shared care between primary paediatrics, neurodisability, epilepsy, and the sleep serviceLevel 1: Recognition that sleep disorders are common and consequential in children with neurological diseaseLevel 2: Sleep hygiene, behavioural therapy, melatonin for insomnia of autism, and iron for restless legsLevel 3: Polysomnography, multiple sleep latency testing, and ventilatory support for complex neurodisabilityThe four-cluster classification and the bidirectional mechanism of sleep and the brainDiagnostic criteria for narcolepsy (mean sleep latency 8 minutes or less, 2 or more sleep-onset REM periods, orexin below 110 pg per mL) and restless legs (low ferritin)Evidence base for melatonin in autism and intravenous ferric carboxymaltose in refractory restless legsAssessment of the sleepy, snoring, or restless child including cataplexy and the sleep diaryStepped management explained to a family, emphasising treatable drivers and safetyRecognition of red flags: cataplexy, nocturnal hypoventilation, and possible nocturnal frontal lobe epilepsyAmerican Academy of Sleep Medicine scoring rules and the apnoea-hypopnoea and periodic limb movement indicesMelatonin trial evidence for insomnia of autism spectrum disorder and iron for restless legsSleep-disordered breathing in cerebral palsy and the role of polysomnography and airway or ventilatory supportRecognition of sleep disorders as common, consequential, and treatable in children with neurological diseaseStepped management built on sleep hygiene, behavioural therapy, and targeted pharmacotherapy and ventilationFamily communication around the bidirectional link between sleep, seizures, cognition, and behaviourCanadian approach to case-finding sleep disorders in the neurodisability and epilepsy clinicPolysomnography, multiple sleep latency testing, and targeted iron and melatonin therapyCounselling on the favourable prognosis when sleep disorders are recognised and treated, and the role of telehealth for remote families

Your progress

Saved locally on this device.

Practise this topic

Target exams

RACP General PaediatricsRACP DWERACP DCEMRCPCH TheoryMRCPCH ClinicalABP General PediatricsRCPSC Pediatrics

Red flags

Life stages

infantpreschoolschool-ageadolescentyoung-adult-transition

Care settings

preventive-medical-homecommunity-schooloutpatientwardpicutelehealth

Clinical exam formats

written-only

Board mappings

The fellowship answer

Sleep disorders with neurological disease are disturbances of sleep onset, maintenance, architecture, or breathing that arise in, or travel with, a child's underlying neurological condition, and they are best understood through a single bidirectional idea: the brain makes sleep, and broken sleep feeds back to worsen the brain. A child with autism who cannot settle, a child with cerebral palsy who snores and desaturates, and a previously well child who falls asleep in class and slumps when laughing are all examples of the same principle, that the nervous system and sleep are one system. [9] [7]

The framework that earns marks is the four-cluster classification of the International Classification of Sleep Disorders. The dyssomnias are the disorders in which the child cannot get enough sleep. The sleep-related breathing disorders are those in which the airway or respiratory drive fails. The parasomnias are those in which sleep-state transition misfires. The sleep-related movement disorders are those in which motor programmes intrude into sleep. Each cluster has a characteristic presentation, a targeted investigation, and a stepped management, and the high-yield fact is that most of these disorders are treatable when recognised. [10]

Management is stepped and begins with sleep hygiene and behavioural therapy for every child, because unstructured routines and screen exposure drive much of the insomnia of neurodevelopmental disorders. Targeted therapy follows: prolonged-release melatonin, trial-proven for insomnia of autism, iron for restless legs syndrome with low ferritin, adenotonsillectomy or continuous positive airway pressure for obstructive sleep apnoea of cerebral palsy, and non-invasive ventilation for the nocturnal hypoventilation of neuromuscular disease. [2] [7] Narcolepsy type 1, the loss of orexin neurons, is now directly treatable with orexin receptor 2 agonists. The prognosis is good when the disorder is recognised, and the main work of the neurodisability clinic is case-finding, because untreated sleep disturbance silently worsens seizures, cognition, behaviour, and tone. [1] [12]

Overview & Definition

Picture the eight-year-old with severe cerebral palsy who is brought in because he sleeps poorly, snores loudly, and has become harder to manage by day, and whose parents assume the restlessness is just part of his condition. That child carries the whole teaching point of paediatric sleep in neurology: the sleep problem is real, it is caused by the hypotonic airway of his cerebral palsy, and treating it will improve not only his nights but also his daytime tone, his seizures, and his family's exhausted quality of life. The clinician who grasps this treats the sleep and the neurology as one, rather than dismissing the nights as an unchangeable feature of the diagnosis. [7] [8]

A sleep disorder, in this context, is any disturbance of sleep onset, maintenance, architecture, or breathing that is either caused by the underlying neurological disease or so closely entwined with it that the two must be managed together. The definition matters because it directs the clinician away from two common errors, attributing all sleep disturbance to behaviour and prescribing a sedative, and attributing it all to the neurological disease and giving up. Most sleep disturbance in children with neurological disease has a specific, treatable driver, whether that driver is an obstructed airway, an iron-deficient restless leg, an overconsolidated epilepsy, or a disrupted circadian rhythm. [10]

The unifying mechanism, and the idea that earns the most marks at viva, is that the relationship is bidirectional. The brain generates and gates sleep through the hypothalamic orexin neurons, the suprachiasmatic circadian pacemaker, and the brainstem REM-atonia circuit, and neurological disease attacks these systems. In the other direction, fragmented and hypoxic sleep feeds back to lower the seizure threshold, impair learning and memory consolidation, magnify the behavioural dysregulation of autism and attention-deficit or hyperactivity disorder, and increase spasticity. Treating sleep is therefore not a comfort measure but a direct treatment of the neurological condition. [1] [9]

Across Australia and New Zealand, practice follows the American Academy of Sleep Medicine scoring rules for polysomnography, the paediatric sleep service within tertiary children's hospitals, and a shared-care model in which the primary paediatrician case-finds and coordinates while the sleep service performs polysomnography and supervises ventilation. Rural and remote families rely on pulse oximetry screening in the community and telehealth links to the specialist sleep laboratory, with non-invasive ventilation initiated and monitored jointly between the regional centre and the tertiary service.

[11] [7]

Paediatrics Fellowship Pro

You have read the opening of this topic. The complete unit — every section and its primary-source references — is part of the Paediatrics Fellowship fellowship atlas.

References12Show ledger

[1]Scammell TE Narcolepsy. N Engl J Med, 2015.PMID 26716917
[2]Gringras P, Nir T, Breddy J, et al Efficacy and safety of pediatric prolonged-release melatonin for insomnia in children with autism spectrum disorder. J Am Acad Child Adolesc Psychiatry, 2017.PMID 29096777
[3]Maras A, Schroder CM, Malow BA, et al Long-term efficacy and safety of pediatric prolonged-release melatonin for insomnia in children with autism spectrum disorder. J Child Adolesc Psychopharmacol, 2018.PMID 30132686
[4]DelRosso LM, Picchietti DL, Sharon D, et al Periodic limb movement disorder in children: a systematic review. Sleep Med Rev, 2024.PMID 38652932
[5]DelRosso LM, Ferri R, Chen ML, et al Clinical efficacy and safety of intravenous ferric carboxymaltose treatment of pediatric restless legs syndrome and periodic limb movement disorder. Sleep Med, 2021.PMID 34562823
[6]Ferri R, Picchietti DL, Sharon D, et al Rethinking pediatric periodic limb movement disorder: a clinical review of pediatric PLMD and consensus criteria for an updated pediatric diagnostic category. Sleep Med, 2025.PMID 40203610
[7]Vanhaverbeke K, Selçuk M, Ersu R, et al. Sleep-disordered breathing in children with neurodisabilities. Eur Respir Rev, 2026.PMID 42128483
[8]Al-Iede M, Al-Ani A, Libdeh AA, et al Sleep-disordered breathing in children with cerebral palsy compared to non-neurological controls: a prospective study. Neurol Int, 2026.PMID 41893051
[9]Wang H, Yu L, Hu S, et al Prevalence and associated factors of sleep disorders in children and adolescents with autism spectrum disorder: a meta-analysis and systematic review. BMC Psychiatry, 2026.PMID 42192550
[10]Nunes ML, El Halal CDS Sleep disorders in children and adolescents with neurodevelopmental and neurological disorders: what evidence do we have with the use of non-pharmacological interventions? Front Sleep, 2026.PMID 41929654
[11]Berry RB, Brooks R, Gamaldo C, et al AASM Scoring Manual updates for 2017 (version 2.4). J Clin Sleep Med, 2017.PMID 28416048
[12]Dauvilliers Y, Mignot E, Del Rio Villegas R, et al Oral orexin receptor 2 agonist in narcolepsy type 1. N Engl J Med, 2023.PMID 37494485

Sleep disorders with neurological disease

high12 referencesUpdated 16 July 202626 min readVerification in progress

Practise this topic

Overview & Definition

[11]

[7]

Paediatrics Fellowship Pro

You have read the opening of this topic. The complete unit — every section and its primary-source references — is part of the Paediatrics Fellowship fellowship atlas.

References12Show ledger

[1]Scammell TE Narcolepsy. N Engl J Med, 2015.PMID 26716917
[2]Gringras P, Nir T, Breddy J, et al Efficacy and safety of pediatric prolonged-release melatonin for insomnia in children with autism spectrum disorder. J Am Acad Child Adolesc Psychiatry, 2017.PMID 29096777
[3]Maras A, Schroder CM, Malow BA, et al Long-term efficacy and safety of pediatric prolonged-release melatonin for insomnia in children with autism spectrum disorder. J Child Adolesc Psychopharmacol, 2018.PMID 30132686
[4]DelRosso LM, Picchietti DL, Sharon D, et al Periodic limb movement disorder in children: a systematic review. Sleep Med Rev, 2024.PMID 38652932
[5]DelRosso LM, Ferri R, Chen ML, et al Clinical efficacy and safety of intravenous ferric carboxymaltose treatment of pediatric restless legs syndrome and periodic limb movement disorder. Sleep Med, 2021.PMID 34562823
[6]Ferri R, Picchietti DL, Sharon D, et al Rethinking pediatric periodic limb movement disorder: a clinical review of pediatric PLMD and consensus criteria for an updated pediatric diagnostic category. Sleep Med, 2025.PMID 40203610
[7]Vanhaverbeke K, Selçuk M, Ersu R, et al. Sleep-disordered breathing in children with neurodisabilities. Eur Respir Rev, 2026.PMID 42128483
[8]Al-Iede M, Al-Ani A, Libdeh AA, et al Sleep-disordered breathing in children with cerebral palsy compared to non-neurological controls: a prospective study. Neurol Int, 2026.PMID 41893051
[9]Wang H, Yu L, Hu S, et al Prevalence and associated factors of sleep disorders in children and adolescents with autism spectrum disorder: a meta-analysis and systematic review. BMC Psychiatry, 2026.PMID 42192550
[10]Nunes ML, El Halal CDS Sleep disorders in children and adolescents with neurodevelopmental and neurological disorders: what evidence do we have with the use of non-pharmacological interventions? Front Sleep, 2026.PMID 41929654
[11]Berry RB, Brooks R, Gamaldo C, et al AASM Scoring Manual updates for 2017 (version 2.4). J Clin Sleep Med, 2017.PMID 28416048
[12]Dauvilliers Y, Mignot E, Del Rio Villegas R, et al Oral orexin receptor 2 agonist in narcolepsy type 1. N Engl J Med, 2023.PMID 37494485